Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Total Liabilities 2010-2025 | MKKGY

Merck total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Merck total liabilities for the quarter ending March 31, 2025 were $20.517B, a 11.82% decline year-over-year.
  • Merck total liabilities for 2024 were $23.351B, a 0.76% decline from 2023.
  • Merck total liabilities for 2023 were $23.53B, a 0.83% decline from 2022.
  • Merck total liabilities for 2022 were $23.728B, a 16.25% decline from 2021.
  
Merck Annual Total Liabilities
(Millions of US $)
2024 $23,351
2023 $23,530
2022 $23,728
2021 $28,332
2020 $28,305
2019 $29,006
2018 $23,213
2017 $24,362
2016 $26,781
2015 $27,911
2014 $18,888
2013 $12,950
2012 $14,441
2011 $16,196
2010 $0
2009 $0
Merck Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $20,517
2024-12-31 $23,351
2024-09-30 $23,915
2024-06-30 $22,894
2024-03-31 $23,267
2023-12-31 $23,530
2023-09-30 $23,523
2023-06-30 $24,000
2023-03-31 $24,052
2022-12-31 $23,728
2022-09-30 $22,759
2022-06-30 $24,146
2022-03-31 $26,086
2021-12-31 $28,332
2021-09-30 $27,307
2021-06-30 $28,657
2021-03-31 $30,029
2020-12-31 $28,305
2020-09-30 $29,500
2020-06-30 $28,404
2020-03-31 $28,841
2019-12-31 $29,006
2019-09-30 $26,560
2019-06-30 $24,721
2019-03-31 $23,898
2018-12-31 $23,213
2018-09-30 $23,711
2018-06-30 $24,966
2018-03-31 $25,900
2017-12-31 $24,362
2017-09-30 $25,902
2017-06-30 $25,308
2017-03-31 $25,438
2016-12-31 $26,781
2016-09-30 $26,505
2016-06-30 $27,302
2016-03-31 $27,149
2015-12-31 $27,911
2015-09-30 $20,298
2015-06-30 $17,589
2015-03-31 $19,118
2014-12-31 $18,888
2014-09-30 $14,512
2014-06-30 $14,077
2014-03-31 $13,384
2013-12-31 $12,950
2013-09-30 $13,969
2013-06-30 $14,698
2013-03-31 $15,110
2012-12-31 $14,441
2012-09-30 $14,645
2012-06-30 $14,601
2012-03-31
2011-12-31 $16,196
2011-09-30
2011-06-30 $16,602
2011-03-31
2010-12-31
2010-09-30 $16,096
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.079B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.033B 26.94
Zoetis (ZTS) United States $68.299B 24.78
Takeda Pharmaceutical (TAK) Japan $47.729B 9.74
Daiichi Sankyo, - (DSNKY) Japan $47.567B 24.38
BeOne Medicines - (ONC) Switzerland $35.221B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.101B 0.00
Summit Therapeutics (SMMT) United States $19.827B 0.00
Shionogi (SGIOY) Japan $15.193B 0.00
United Therapeutics (UTHR) United States $14.124B 12.22
Neurocrine Biosciences (NBIX) United States $13.181B 39.32
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.601B 0.00
Eisai (ESAIY) $9.204B 10.38
Madrigal Pharmaceuticals (MDGL) United States $8.212B 0.00
Corcept Therapeutics (CORT) United States $7.560B 63.49
Grifols, S.A (GRFS) Spain $7.371B 0.00
Ionis Pharmaceuticals (IONS) United States $6.978B 0.00
Stevanato Group S.p.A (STVN) Italy $6.850B 40.39
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $3.807B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.968B 14.10
Crinetics Pharmaceuticals (CRNX) United States $2.893B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.824B 0.00
Hypermarcas (HYPMY) Brazil $2.676B 20.12
Catalyst Pharmaceuticals (CPRX) United States $2.476B 8.29
Centessa Pharmaceuticals (CNTA) United Kingdom $2.417B 0.00
Ocular Therapeutix (OCUL) United States $2.196B 0.00
Dyne Therapeutics (DYN) United States $1.761B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.757B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.615B 24.06
Guardian Pharmacy Services (GRDN) United States $1.495B 0.00
Ardelyx (ARDX) United States $1.439B 0.00
Harrow (HROW) United States $1.436B 0.00
ARS Pharmaceuticals (SPRY) United States $1.436B 0.00
Evotec AG (EVO) Germany $1.335B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.329B 0.00
Xeris Biopharma Holdings (XERS) United States $1.240B 0.00
Enliven Therapeutics (ELVN) United States $1.198B 0.00
Collegium Pharmaceutical (COLL) United States $1.189B 6.50
Cronos Group (CRON) Canada $0.908B 0.00
Akebia Therapeutics (AKBA) United States $0.862B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.713B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.709B 7.30
ProKidney (PROK) United States $0.691B 0.00
Theravance Biopharma (TBPH) United States $0.662B 54.79
KalVista Pharmaceuticals (KALV) United States $0.643B 0.00
Relay Therapeutics (RLAY) United States $0.610B 0.00
Bioventus (BVS) United States $0.609B 14.74
Siga Technologies (SIGA) United States $0.609B 7.52
Organogenesis (ORGO) United States $0.600B 0.00
Elite Pharmaceuticals (ELTP) United States $0.581B 0.00
Tourmaline Bio (TRML) United States $0.580B 0.00
Oruka Therapeutics (ORKA) United States $0.576B 0.00
USANA Health Sciences (USNA) United States $0.555B 11.39
Xencor (XNCR) United States $0.548B 0.00
Zevra Therapeutics (ZVRA) United States $0.529B 0.00
Savara (SVRA) United States $0.525B 0.00
Nektar Therapeutics (NKTR) United States $0.518B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.450B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Aquestive Therapeutics (AQST) United States $0.410B 0.00
Nanobiotix S.A (NBTX) France $0.379B 0.00
4D Molecular Therapeutics (FDMT) United States $0.339B 0.00
Larimar Therapeutics (LRMR) United States $0.332B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Altimmune (ALT) United States $0.320B 0.00
AleAnna (ANNA) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 19.01
OmniAb (OABI) United States $0.247B 0.00
Galectin Therapeutics (GALT) United States $0.229B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Lyell Immunopharma (LYEL) United States $0.203B 0.00
Aclaris Therapeutics (ACRS) United States $0.203B 0.00
MediWound (MDWD) Israel $0.196B 0.00
Korro Bio (KRRO) United States $0.190B 0.00
China SXT Pharmaceuticals (SXTC) China $0.186B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.167B 25.75
Journey Medical (DERM) United States $0.162B 0.00
MEI Pharma (MEIP) United States $0.158B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Avita Medical (RCEL) United States $0.150B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.130B 0.00
Profound Medical (PROF) Canada $0.128B 0.00
Avalo Therapeutics (AVTX) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.110B 0.00
Liminatus Pharma (LIMN) United States $0.104B 0.00
Dominari Holdings (DOMH) United States $0.098B 0.00
Surrozen (SRZN) United States $0.095B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.38
BioNxt Solutions (BNXTF) Canada $0.086B 0.00
VAXART, INC (VXRT) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Context Therapeutics (CNTX) United States $0.071B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Inotiv (NOTV) United States $0.065B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
DURECT (DRRX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Karyopharm Therapeutics (KPTI) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Wellgistics Health (WGRX) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 28.45
Tempest Therapeutics (TPST) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Enlivex Therapeutics (ENLV) Israel $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Klotho Neurosciences (KLTO) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
FibroGen (FGEN) United States $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Mural Oncology (MURA) Ireland $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.029B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.020B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.02
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.18
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.52
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00